XML 45 R35.htm IDEA: XBRL DOCUMENT v3.25.3
STOCK BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Changes in Company's Nonvested Restricted Stock Awards
A summary of changes in the Company’s nonvested Restricted Stock Awards (“RSAs”) under the Omnibus Incentive Plan for the nine months ended September 30, 2025 were as follows:
Nonvested RSAsSharesWeighted-Average
Grant-Date
Fair Value
Nonvested at January 1, 202548,868 90.18 
Granted— — 
Vested(48,293)90.21 
Forfeited(575)87.77 
Nonvested at September 30, 2025— — 
Schedule of Changes in Company's Nonvested Restricted Stock Units
A summary of changes in the Company’s nonvested Restricted Stock Units (“RSUs”) under the Omnibus Incentive Plan for the nine months ended September 30, 2025 were as follows:
Nonvested RSUsSharesWeighted-Average
Grant-Date
Fair Value
Nonvested at January 1, 2025224,568 66.07 
Granted115,572 55.77 
Vested(95,137)69.51 
Forfeited(43,793)59.51 
Nonvested at September 30, 2025201,210 59.95 
Schedule of Changes in Company's Nonvested Performance Stock Units
A summary of changes in the Company’s nonvested Market Based Performance Stock Units (“Market Based PSUs”) under the Omnibus Incentive Plan for the nine months ended September 30, 2025 were as follows:
Nonvested Market Based PSUsSharesWeighted-Average
Grant-Date
Fair Value
Nonvested at January 1, 2025167,780 $93.10 
Granted115,508 93.21 
Performance adjustment(19,595)— 
Vested(9,793)89.79 
Forfeited(7,937)103.82 
Nonvested at September 30, 2025245,963 $93.86 
Schedule of Fair Value of Market Based Performance Stock Units, Weighted Average Assumptions
The fair value of the Market Based PSUs granted was determined using the following weighted-average assumptions:
Nine Months Ended September 30,
20252024
Grant dateMay 1, 2025May 1, 2024
Performance period3.00 years3.00 years
Stock price$54.38 $72.00 
Triumph Financial stock price volatility42.22 %42.31 %
Risk-free rate3.62 %4.67 %
Schedule of Changes in Company's Stock Options
A summary of the changes in the Company’s stock options under the Omnibus Incentive Plan for the nine months ended September 30, 2025 were as follows:
Stock OptionsSharesWeighted-Average
Exercise Price
Weighted-Average
Remaining
Contractual Term
(In Years)
Aggregate
Intrinsic Value
(In Thousands)
Outstanding at January 1, 2025257,603 $49.68 
Granted91,552 54.38 
Exercised(6,667)32.76 
Forfeited(9,503)64.28 
Expired(452)$72.00 
Outstanding at September 30, 2025332,533 $50.87 6.33$2,306 
Fully vested shares and shares expected to vest at September 30, 2025332,533 $50.87 6.33$2,306 
Shares exercisable at September 30, 2025178,312 $44.63 4.09$2,306 
Schedule of Information Related to Stock Options
Information related to the stock options for the nine months ended September 30, 2025 and 2024 was as follows:
Nine Months Ended September 30,
(Dollars in thousands, except per share amounts)20252024
Aggregate intrinsic value of options exercised$214 $895 
Cash received from option exercises, net218 425 
Tax benefit realized from option exercises45 188 
Weighted average fair value per share of options granted$28.35 $37.30 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions
The fair value of the stock options granted was determined using the following weighted-average assumptions:
Nine Months Ended September 30,
20252024
Risk-free interest rate3.88 %4.52 %
Expected term6.25 years6.25 years
Expected stock price volatility48.48 %46.50 %
Dividend yield— —